カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

ランレオチド薬の世界市場2022：60mg、90mg、120mg

■ 英語タイトル：Global Lanreotide Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3846）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3846
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ランレオチド薬の世界市場2022：60mg、90mg、120mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のランレオチド薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のランレオチド薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ランレオチド薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・60mg、90mg、120mg

アプリケーション別セグメントは次のように区分されます。
・病院、薬局

世界のランレオチド薬市場の主要な市場プレーヤーは以下のとおりです。
・IPSEN

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、ランレオチド薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なランレオチド薬メーカーの企業概要、2019年～2022年までのランレオチド薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なランレオチド薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ランレオチド薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのランレオチド薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのランレオチド薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびランレオチド薬の産業チェーンを掲載しています。
・第13、14、15章では、ランレオチド薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– ランレオチド薬の概要
– 種類別分析（2017年vs2021年vs2028年）：60mg、90mg、120mg
– 用途別分析（2017年vs2021年vs2028年）：病院、薬局
– 世界のランレオチド薬市場規模・予測
– 世界のランレオチド薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– IPSEN
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：60mg、90mg、120mg
・用途別分析2017年-2028年：病院、薬局
・ランレオチド薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ランレオチド薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ランレオチド薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ランレオチド薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ランレオチド薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Lanreotide Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lanreotide Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 60 mg
1.2.3 90 mg
1.2.4 120 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Lanreotide Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Lanreotide Drugs Market Size & Forecast
1.4.1 Global Lanreotide Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lanreotide Drugs Sales in Volume (2017-2028)
1.4.3 Global Lanreotide Drugs Price (2017-2028)
1.5 Global Lanreotide Drugs Production Capacity Analysis
1.5.1 Global Lanreotide Drugs Total Production Capacity (2017-2028)
1.5.2 Global Lanreotide Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lanreotide Drugs Market Drivers
1.6.2 Lanreotide Drugs Market Restraints
1.6.3 Lanreotide Drugs Trends Analysis
2 Manufacturers Profiles
2.1 IPSEN
2.1.1 IPSEN Details
2.1.2 IPSEN Major Business
2.1.3 IPSEN Lanreotide Drugs Product and Services
2.1.4 IPSEN Lanreotide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lanreotide Drugs Breakdown Data by Manufacturer
3.1 Global Lanreotide Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lanreotide Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lanreotide Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Lanreotide Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Lanreotide Drugs Manufacturer Market Share in 2021
3.5 Global Lanreotide Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lanreotide Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lanreotide Drugs Market Size by Region
4.1.1 Global Lanreotide Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Lanreotide Drugs Revenue by Region (2017-2028)
4.2 North America Lanreotide Drugs Revenue (2017-2028)
4.3 Europe Lanreotide Drugs Revenue (2017-2028)
4.4 Asia-Pacific Lanreotide Drugs Revenue (2017-2028)
4.5 South America Lanreotide Drugs Revenue (2017-2028)
4.6 Middle East and Africa Lanreotide Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lanreotide Drugs Sales in Volume by Type (2017-2028)
5.2 Global Lanreotide Drugs Revenue by Type (2017-2028)
5.3 Global Lanreotide Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lanreotide Drugs Sales in Volume by Application (2017-2028)
6.2 Global Lanreotide Drugs Revenue by Application (2017-2028)
6.3 Global Lanreotide Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lanreotide Drugs Sales by Type (2017-2028)
7.2 North America Lanreotide Drugs Sales by Application (2017-2028)
7.3 North America Lanreotide Drugs Market Size by Country
7.3.1 North America Lanreotide Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Lanreotide Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lanreotide Drugs Sales by Type (2017-2028)
8.2 Europe Lanreotide Drugs Sales by Application (2017-2028)
8.3 Europe Lanreotide Drugs Market Size by Country
8.3.1 Europe Lanreotide Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Lanreotide Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lanreotide Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Lanreotide Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Lanreotide Drugs Market Size by Region
9.3.1 Asia-Pacific Lanreotide Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lanreotide Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lanreotide Drugs Sales by Type (2017-2028)
10.2 South America Lanreotide Drugs Sales by Application (2017-2028)
10.3 South America Lanreotide Drugs Market Size by Country
10.3.1 South America Lanreotide Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Lanreotide Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lanreotide Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Lanreotide Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Lanreotide Drugs Market Size by Country
11.3.1 Middle East & Africa Lanreotide Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lanreotide Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lanreotide Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lanreotide Drugs
12.3 Lanreotide Drugs Production Process
12.4 Lanreotide Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lanreotide Drugs Typical Distributors
13.3 Lanreotide Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lanreotide Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lanreotide Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. IPSEN Basic Information, Manufacturing Base and Competitors
Table 4. IPSEN Major Business
Table 5. IPSEN Lanreotide Drugs Product and Services
Table 6. IPSEN Lanreotide Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Lanreotide Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Lanreotide Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Lanreotide Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Lanreotide Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Lanreotide Drugs Production Site of Key Manufacturer
Table 12. Lanreotide Drugs New Entrant and Capacity Expansion Plans
Table 13. Lanreotide Drugs Mergers & Acquisitions in the Past Five Years
Table 14. Global Lanreotide Drugs Sales by Region (2017-2022) & (K Units)
Table 15. Global Lanreotide Drugs Sales by Region (2023-2028) & (K Units)
Table 16. Global Lanreotide Drugs Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Lanreotide Drugs Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 19. Global Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 20. Global Lanreotide Drugs Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Lanreotide Drugs Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Lanreotide Drugs Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Lanreotide Drugs Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 25. Global Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 26. Global Lanreotide Drugs Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Lanreotide Drugs Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Lanreotide Drugs Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Lanreotide Drugs Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 31. North America Lanreotide Drugs Sales by Country (2023-2028) & (K Units)
Table 32. North America Lanreotide Drugs Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Lanreotide Drugs Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 35. North America Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 36. North America Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 37. North America Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Europe Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 39. Europe Lanreotide Drugs Sales by Country (2023-2028) & (K Units)
Table 40. Europe Lanreotide Drugs Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Lanreotide Drugs Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 43. Europe Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 44. Europe Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 45. Europe Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Lanreotide Drugs Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Lanreotide Drugs Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Lanreotide Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Lanreotide Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 54. South America Lanreotide Drugs Sales by Country (2017-2022) & (K Units)
Table 55. South America Lanreotide Drugs Sales by Country (2023-2028) & (K Units)
Table 56. South America Lanreotide Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Lanreotide Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 59. South America Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 60. South America Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 61. South America Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Lanreotide Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Lanreotide Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Lanreotide Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Lanreotide Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Lanreotide Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Lanreotide Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Lanreotide Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Lanreotide Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Lanreotide Drugs Raw Material
Table 71. Key Manufacturers of Lanreotide Drugs Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Lanreotide Drugs Typical Distributors
Table 75. Lanreotide Drugs Typical Customers
List of Figures
Figure 1. Lanreotide Drugs Picture
Figure 2. Global Lanreotide Drugs Revenue Market Share by Type in 2021
Figure 3. 60 mg
Figure 4. 90 mg
Figure 5. 120 mg
Figure 6. Global Lanreotide Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Global Lanreotide Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Lanreotide Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Lanreotide Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Lanreotide Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Lanreotide Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Lanreotide Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Lanreotide Drugs Market Drivers
Figure 16. Lanreotide Drugs Market Restraints
Figure 17. Lanreotide Drugs Market Trends
Figure 18. Global Lanreotide Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Lanreotide Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Lanreotide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Lanreotide Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Lanreotide Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Lanreotide Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Lanreotide Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Lanreotide Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Lanreotide Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Lanreotide Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Lanreotide Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Lanreotide Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Lanreotide Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Lanreotide Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Lanreotide Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Lanreotide Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Lanreotide Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Lanreotide Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Lanreotide Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Lanreotide Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Lanreotide Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Lanreotide Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Lanreotide Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Lanreotide Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Lanreotide Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Lanreotide Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Lanreotide Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Lanreotide Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Lanreotide Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Lanreotide Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Lanreotide Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Lanreotide Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Lanreotide Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Lanreotide Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Lanreotide Drugs in 2021
Figure 77. Manufacturing Process Analysis of Lanreotide Drugs
Figure 78. Lanreotide Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ランレオチドの世界市場2022：60mg、90mg、120mg
  • ソマチュリン医薬品の世界市場2022：60mg、90mg、120mg
  • エノキサパリンナトリウムAPI&製剤のグローバル市場2023：20mg/0.2mL、40mg/0.4mL、60mg/0.6mL、80mg/0.8mL、100mg/1mL、120mg/0.8mL、150mg/1mL、300mg/3mL
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3846 )"ランレオチド薬の世界市場2022：60mg、90mg、120mg" (英文：Global Lanreotide Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。